These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6101341)

  • 1. Pharmacokinetics and pharmacodynamics in young normal and elderly hypertensive subjects: a study using sotalol as a model drug.
    Ishizaki T; Hirayama H; Tawara K; Nakaya H; Sato M; Sato K
    J Pharmacol Exp Ther; 1980 Jan; 212(1):173-81. PubMed ID: 6101341
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of arterial hypertension with sotalol, a beta-blocker (author's transl)].
    Klein G; Schnelle K; Schinz A; Oberländer V
    Dtsch Med Wochenschr; 1977 Apr; 102(15):563-9. PubMed ID: 849711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between pharmacokinetics and pharmacodynamics of the beta adrenergic blocking drug sotalol in dogs.
    Ishizaki T; Tawara K
    J Pharmacol Exp Ther; 1979 Nov; 211(2):331-7. PubMed ID: 501565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative beta-adrenoceptor blocking effects and pharmacokinetics of sotalol and propranolol in healthy volunteers].
    Richer C; Maury M; Poirier JM; Duhaze P; Giudicelli JF
    Therapie; 1982; 37(3):259-67. PubMed ID: 6753226
    [No Abstract]   [Full Text] [Related]  

  • 5. Antihypertensive activity of four blocking agents in spontaneously hypertensive rats.
    Roba J; Lambelin G; De Schaepdryver AF
    Arch Int Pharmacodyn Ther; 1972 Nov; 200(1):182-90. PubMed ID: 4404933
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of hypertension with Sotalol (author's transl)].
    Fillastre JP; Godin M; Joire JE; Gauthier A
    Sem Hop; 1979 Nov 18-25; 55(39-40):1825-31. PubMed ID: 232780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive effect of sotalol and propranolol a double-blind crossover study.
    Berglund G
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):21-7. PubMed ID: 401708
    [No Abstract]   [Full Text] [Related]  

  • 8. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers.
    Luzier AB; Killian A; Wilton JH; Wilson MF; Forrest A; Kazierad DJ
    Clin Pharmacol Ther; 1999 Dec; 66(6):594-601. PubMed ID: 10613615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of sotalol and propranolol in mild to moderate essential hypertension.
    Pessina AC; Hlede M; Morandin F; Casiglia E; Gava R; Agnoletto V; Locatelli C; Dal Palu C
    Int J Clin Pharmacol Res; 1983; 3(1):41-5. PubMed ID: 6679506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic, pharmacodynamic, and safety evaluation of an accelerated dose titration regimen of sotalol in healthy middle-aged subjects.
    Barbey JT; Sale ME; Woosley RL; Shi J; Melikian AP; Hinderling PH
    Clin Pharmacol Ther; 1999 Jul; 66(1):91-9. PubMed ID: 10430114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacodynamics and pharmacokinetics of the 5HT1B/1D-agonist zolmitriptan in healthy young and elderly men and women.
    Peck RW; Seaber EJ; Dixon RM; Layton GR; Weatherley BC; Jackson SH; Rolan PE; Posner J
    Clin Pharmacol Ther; 1998 Mar; 63(3):342-53. PubMed ID: 9542478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics and pharmacodynamics of the beta-receptor blocker sotalol].
    Limbourg P; Just H; Kersting F; Lang KF
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1690-4. PubMed ID: 347795
    [No Abstract]   [Full Text] [Related]  

  • 14. Antihypertensive effects of practolol and sotalol.
    Sundquist H; Anttila M; Arstila M
    Clin Pharmacol Ther; 1974 Sep; 16(3):465-72. PubMed ID: 4606232
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic indications for sotalol 160 mg].
    Ginestes J
    Ann Cardiol Angeiol (Paris); 1985 Jan; 34(1):45-52. PubMed ID: 2579609
    [No Abstract]   [Full Text] [Related]  

  • 16. Age, hypertension, and cardiac responses to beta-agonist in humans.
    White M; Fourney A; Leenen FH
    Clin Pharmacol Ther; 1998 Jun; 63(6):663-71. PubMed ID: 9663181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of sotalol after chronic administration to patients with renal insufficiency.
    Berglund G; Descamps R; Thomis JA
    Eur J Clin Pharmacol; 1980 Oct; 18(4):321-6. PubMed ID: 7439252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Controlled clinical investigation of sotalol and alphamethyldopa in hypertensive patients].
    Marinoni C; Lombardi F; Guasconi C; Sportelli G
    Cardiologia; 1984; 29(7-8):405-13. PubMed ID: 6391519
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of mepindolol sulphate.
    Bonelli J; Hitzenberger G; Krause W; Wendt H; Speck U
    Int J Clin Pharmacol Ther Toxicol; 1980 Apr; 18(4):169-76. PubMed ID: 6103882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrocardiographic changes after long-term treatment with sotalol in hypertensive patients.
    Castro M; Descamps R; Thomis JA
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):88-91. PubMed ID: 7061183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.